Back to search
Renal Transplant Osteodystrophy
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Renal Transplant Osteodystrophy trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Renal Transplant Osteodystrophy trials you may qualify forThis is a Phase 2 Multi-Center Clinical Trial (safety and effectiveness trial) in 60 patients (40 denosumab; 20 placebo) who have had a kidney transplant for 12…
Patients with kidney failure have underlying bone disease at the time of transplant. Fractures of various bones can be as high as 22%. Medication required for t…
Hyperparathyroidism (HPT) is common in people with a kidney transplant. Patients with HPT often have high parathyroid hormone (PTH) levels and may have large pa…
The purpose of this study is to determine whether zolendronic acid, a third generation bisphosphonate, is effective in preventing bone loss in the first year af…
The purpose of the study is to evaluate the effects of Cholecalciferol (Vitamin D3) substitution on the posttransplant outcome (glomerular filtration rate as we…